ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Quell Therapeutics Limited

Quell Therapeutics Limited is an active company incorporated on 19 March 2019 with the registered office located in London, Greater London. Quell Therapeutics Limited was registered 6 years ago.
Status
Active
Active since incorporation
Company No
11890040
Private limited company
Age
6 years
Incorporated 19 March 2019
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 28 April 2025 (6 months ago)
Next confirmation dated 28 April 2026
Due by 12 May 2026 (6 months remaining)
Last change occurred 5 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
3rd Floor, Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ
England
Same address for the past 5 years
Telephone
020 70969012
Email
Unreported
Website
Unreported
People
Officers
10
Shareholders
93
Controllers (PSC)
1
Director • Cso • American • Lives in Belgium • Born in Aug 1961
Director • Partner • American • Lives in United States • Born in Jun 1976
Director • British • Lives in England • Born in Nov 1954
Director • Ceo Biotech • British • Lives in England • Born in May 1972
Director • Financial Analyst • American • Lives in United States • Born in Feb 1976
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Mestag Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Eyebiotech Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£60.47M
Decreased by £46.25M (-43%)
Turnover
£43.83M
Increased by £34.67M (+378%)
Employees
146
Increased by 8 (+6%)
Total Assets
£90.77M
Decreased by £36.78M (-29%)
Total Liabilities
-£12.18M
Decreased by £32.94M (-73%)
Net Assets
£78.59M
Decreased by £3.85M (-5%)
Debt Ratio (%)
13%
Decreased by 21.95% (-62%)
Latest Activity
Mr Luke Beshar Appointed
3 Months Ago on 24 Jul 2025
Full Accounts Submitted
3 Months Ago on 23 Jul 2025
Annette Clancy Appointed
4 Months Ago on 13 Jun 2025
Confirmation Submitted
5 Months Ago on 2 Jun 2025
Rachel Brooke Mears Resigned
5 Months Ago on 31 May 2025
Full Accounts Submitted
1 Year Ago on 12 Oct 2024
Confirmation Submitted
1 Year 5 Months Ago on 16 May 2024
Mitre Secretaries Limited Resigned
1 Year 7 Months Ago on 8 Mar 2024
Mr Iain Mcgill Details Changed
5 Years Ago on 1 Jan 2020
Dr Elisa Michela Petris Details Changed
6 Years Ago on 19 Mar 2019
Get Credit Report
Discover Quell Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Change of share class name or designation
Submitted on 1 Oct 2025
Particulars of variation of rights attached to shares
Submitted on 30 Sep 2025
Second filing for the appointment of Mr Luke Beshar as a director
Submitted on 1 Sep 2025
Appointment of Mr Luke Beshar as a director on 24 July 2025
Submitted on 29 Aug 2025
Full accounts made up to 31 December 2024
Submitted on 23 Jul 2025
Appointment of Annette Clancy as a director on 13 June 2025
Submitted on 27 Jun 2025
Termination of appointment of Rachel Brooke Mears as a director on 31 May 2025
Submitted on 26 Jun 2025
Statement of capital following an allotment of shares on 24 February 2025
Submitted on 6 Jun 2025
Confirmation statement made on 28 April 2025 with updates
Submitted on 2 Jun 2025
Full accounts made up to 31 December 2023
Submitted on 12 Oct 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year